DNA Repair Defects as a Therapeutic Target in Advanced Prostate Cancer: The Role of PARP Inhibitors

In this downloadable slideset, Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD, reviews the available clinical data on PARP inhibitors in advanced prostate cancer and explores how these agents may affect management strategies for patients in the near future.
Johann Sebastian de Bono, MB, ChB, FRCP, MSc, PhD
Program Director
Format: Microsoft PowerPoint (.ppt)
File Size: 6.0 MB
Released: May 25, 2018

Acknowledgements

Jointly provided by Annenberg Center for Health Sciences at Eisenhower and Clinical Care Options, LLC
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

This activity is supported by an educational grant from
AstraZeneca

Related Content

In this Clinical Care Options (CCO) slideset, Dr. Elizabeth R. Plimack provides insights on managing adverse events and treatment options for advanced RCC after previous therapy

Elizabeth R. Plimack, MD, MS Released: February 13, 2020

In this Clinical Care Options (CCO) slideset, Dr. Martin H. Voss provides insights on the use of first-line systemic therapy for intermediate-risk/poor-risk RCC

Martin H. Voss, MD Released: February 13, 2020

In this Clinical Care Options (CCO) slideset, Dr. M. Dror Michaelson provides insights on the use of first-line systemic therapy for favorable-risk RCC

M. Dror Michaelson, MD, PhD Released: February 13, 2020

CME-certified Webcast of a CCO symposium at SITC 2019 featuring expert perspectives on optimal integration of immunotherapy into care of patients with bladder cancer

Elizabeth R. Plimack, MD, MS
Program Director
Matthew Galsky, MD
Physicians: maximum of 1.0 AMA PRA Category 1 Credit Released: January 23, 2020 Expiration: January 22, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?